Error message

The page you requested does not exist. For your convenience, a search was performed using the query trials ion.

Search results

  1. Professor James Brenton

    ... in resistance has been to develop novel phase II clinical trials with sequential collection and profiling of ovarian cancer tissues ...

  2. Dr Massimiliano di Pietro

    ... recent multi-centre studies led by our group (TIME and ACE-B trials) have demonstrated that it is possible to increase diagnostic accuracy ...

  3. Dr Michael Gattens

    ... am principal investigator for a number of national leukaemia trials, and coinvestigator for trials of new haemophilia factor concentrates in paediatric haemophilia ...

  4. Dr Phil Jewsbury

    ... pre-clinical candidate drugs to proof-of-concept Phase 2 trials. Currently a Senior Project Director in AstraZeneca Oncology ...

  5. Dr Richard Baird

    Early phase clinical trials, including expertise in: - first-in-human studies & drug combination trials - new small molecule & antibody therapeutics - development of ... cancer therapeutics. Investigator-initiated clinical trials funded by:  - Cancer Research UK  - EU HORIZON 2020 - AntiCancer ...

  6. Professor Richard Gilbertson

    ... Program and founding Director of the Molecular Clinical Trials Core before being appointed as the Comprehensive Cancer Center Director, ...

  7. Mr Richard Skells

    ... studies coordinated by CCTU and Cambridge Cancer Trials Centre. ...

  8. Professor Robert Rintoul

    ... at Royal Papworth Hospital and Director of the Papworth Trials Unit Collaboration. He is co-lead of the CRUK Cambridge Centre Thoracic ... Rintoul’s research is focused around clinical trials, translational research and tissue banking in malignant mesothelioma and ...

  9. Dr Robert Thomas

    ... completed and published a number of national research trials including; an evaluation of the impact of exercise in relation to ...

  10. Dr Tim Mitchell

    ... CRT Pioneer Fund. This programme will start Phase 1 clinical trials at the Royal Marsden Hospital in June 2016. SKIL® (Sareum Kinase ...

  11. Dr Ali Amin Al Olama

    My research has focused on discovery of genetic risk factors of prostate cancer through genome-wide association studies and fine-mapping. I am a core member of an international consortium PRACTICAL (Prostate Cancer Association Group to Investigate...

  12. Mr Arqum Anwar

    Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...

  13. Dr Andreas Bender

    Previously affiliated with the Lead Discovery Informatics (LDI) group of Novartis in Cambridge/MA, I am now developing and applying cheminformatics techniques in the drug discovery field in my group with the University of Cambridge. Our expertise ranges...

  14. Dr Alvis Brazma

    High throughput (microarray, sequencing) data analysis. Data integration. Cell cycle. I am in charge of running and developing the transcriptomics data repository ArrayExpress.

  15. Dr Alejandra Bruna

    We aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in the regulation of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the...

  16. Professor Antonis Antoniou

    My main research interest is the development and application of statistical modelling techniques for addressing clinical questions, and the development of risk prediction tools which are used in clinical practice. ...

  17. Dr Annalise Katz-Summercorn

    Early detection in oesophageal adenocarcinoma

  18. Dr Catherine Lindon

    My lab studies cell division in human cells, with particular focus on regulation by ubiquitin-mediated proteolysis. We use time-lapse fluorescence imaging of live cells to measure proteolysis of substrates in real time, and to study the role of...

  19. Professor Adrian Liston

    We are focussed on understanding the biology of regulatory T cells within the tissues. How they migrate there, what controls their numbers and their functions, both immunological and tissue homeostatic in nature. Our approach is to identify key unknowns...

  20. Dr Alison Dunning

    Work in the Centre for Cancer Genetic Epidemiology "wet lab" involves running very high throughput SNP-chip genotyping and Next Generation Sequencing (NGS) studies. We search for genetic risk factors for both cancer susceptibility and treatment-response...

Pages